AmeriCann, Inc. (ACAN) Launches New Line of Cannabis-Infused Products
AmeriCann (OTCQX: ACAN), developer of the proposed Massachusetts Medical Cannabis Center (MMCC) cultivation and processing facility, today unveiled its latest line of nutraceutical-grade cannabis-infused products. AmeriCann will license the intellectual property behind “Solanna” to regulated cannabis businesses looking to offer healthier alternatives to smoking, including capsules, topical lotions and balms, sublingual tinctures, oral dissolving film, trans-dermal applications, and oil cartridges for vaporizing. The company says it intends to later expand the product line to include edible products, health drinks, and branded concentrates offered at varying dosages. To view the full press release, visit: http://nnw.fm/lUwH6 About AmeriCann, Inc. AmeriCann is a…
